Zai Lab (ZLAB) Net Margin Growth (3y) (2023 - 2026)

Zai Lab (ZLAB) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -569.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 4,144.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Zai Lab 21.37 Bn 21.37 Bn -34.26 Mn -117,886.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -117,886.00
Dec 31, 2025 11,486.00
Sep 30, 2025 -485,744.00
Jun 30, 2025 -423,891.00
Mar 31, 2025 13,290.00
Dec 31, 2024 40,748.00
Jun 30, 2024 -1.97 Mn
Mar 31, 2024 109,723.00
Dec 31, 2023 47,136.00
Sep 30, 2023 33,517.00
Mar 31, 2023 50,568.00